A detailed history of Dimensional Fund Advisors LP transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,420,995 shares of ADPT stock, worth $6.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,420,995
Previous 1,369,097 3.79%
Holding current value
$6.66 Million
Previous $4.96 Million 46.79%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$3.37 - $5.12 $174,896 - $265,717
51,898 Added 3.79%
1,420,995 $7.28 Million
Q2 2024

Aug 09, 2024

SELL
$2.34 - $3.96 $876,374 - $1.48 Million
-374,519 Reduced 21.48%
1,369,097 $4.96 Million
Q1 2024

May 10, 2024

SELL
$2.88 - $4.8 $1.14 Million - $1.89 Million
-394,575 Reduced 18.45%
1,743,616 $5.6 Million
Q4 2023

Feb 07, 2024

SELL
$3.46 - $5.33 $529,331 - $815,415
-152,986 Reduced 6.68%
2,138,191 $10.5 Million
Q3 2023

Nov 09, 2023

BUY
$5.07 - $8.44 $716,041 - $1.19 Million
141,231 Added 6.57%
2,291,177 $12.5 Million
Q2 2023

Aug 09, 2023

BUY
$6.19 - $8.78 $3.1 Million - $4.4 Million
501,585 Added 30.43%
2,149,946 $14.4 Million
Q1 2023

May 12, 2023

BUY
$7.8 - $10.11 $4.9 Million - $6.36 Million
628,622 Added 61.65%
1,648,361 $14.6 Million
Q4 2022

Feb 09, 2023

BUY
$6.26 - $9.34 $2.12 Million - $3.16 Million
338,662 Added 49.72%
1,019,739 $7.79 Million
Q3 2022

Nov 10, 2022

BUY
$6.5 - $12.67 $1.73 Million - $3.37 Million
265,593 Added 63.92%
681,077 $4.85 Million
Q2 2022

Aug 12, 2022

SELL
$6.4 - $14.73 $303,616 - $698,791
-47,440 Reduced 10.25%
415,484 $3.36 Million
Q1 2022

May 13, 2022

SELL
$10.12 - $28.9 $117,230 - $334,777
-11,584 Reduced 2.44%
462,924 $6.43 Million
Q4 2021

Feb 09, 2022

BUY
$25.17 - $36.85 $6.67 Million - $9.76 Million
264,902 Added 126.38%
474,508 $13.3 Million
Q3 2021

Nov 12, 2021

BUY
$30.02 - $39.87 $2.51 Million - $3.33 Million
83,549 Added 66.28%
209,606 $7.12 Million
Q2 2021

Aug 12, 2021

SELL
$32.22 - $44.59 $271,775 - $376,116
-8,435 Reduced 6.27%
126,057 $5.15 Million
Q1 2021

May 14, 2021

BUY
$37.26 - $67.74 $1.89 Million - $3.43 Million
50,701 Added 60.51%
134,492 $5.41 Million
Q4 2020

Feb 25, 2021

BUY
$45.01 - $65.47 $3.77 Million - $5.49 Million
83,791 New
83,791 $4.96 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $670M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.